KTIV Dateline NBC December 21, 2015
With. Opdivo, nivolumab. Opdivo is the first and only immunotherapy fda approved based on a Clinical Trial demonstrating longer life. For these patientnt in fact, opdivo significantly increased the chance of living longer versus chemotherapy. Opdivo is different. It works with your immune system. Opdivo can cause your immune system to attack normal organs and tissues in your body and affect how they work. This may happen any time during or after treatment has ended, and may become serious and lead to death. See your doctoright away if you experience new or worsening cough; chest pain; shortnes...